Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Gastrointestinal adverse events following brentuximab vedotin and polatuzumab vedotin therapy.
Journal: Therapeutic advances in medical oncology
Published: May 17, 2025
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Relapsed or Refractory Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 10, 2025
Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapies.
Journal: Discover oncology
Published: September 28, 2024
Pulmonary Immune-Related Adverse Events of PD-1 Versus PD-L1 Checkpoint Inhibitors: A Retrospective Review of Pharmacovigilance.
Journal: Journal of immunotherapy and precision oncology
Published: December 31, 2022
Therapeutic Management of Chronic Lymphocytic Leukemia Presenting with Recurrent Massive Ascites.
Journal: Current oncology (Toronto, Ont.)
Published: August 05, 2022
Showing 1-5 of 5
Last Updated: 09/26/2026